Leelyn Smith’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-473
| Closed | -$220K | – | 138 |
|
|
2024
Q3 | $220K | Sell |
473
-5
| -1% | -$2.33K | 0.04% | 121 |
|
|
2024
Q2 | $224K | Sell |
478
-13
| -3% | -$6.09K | 0.04% | 117 |
|
|
2024
Q1 | $205K | Buy |
+491
| New | +$205K | 0.04% | 124 |
|
|
2023
Q3 | – | Sell |
-853
| Closed | -$300K | – | 119 |
|
|
2023
Q2 | $300K | Sell |
853
-172
| -17% | -$60.5K | 0.07% | 103 |
|
|
2023
Q1 | $323K | Sell |
1,025
-840
| -45% | -$265K | 0.08% | 102 |
|
|
2022
Q4 | $303K | Buy |
1,865
+1,049
| +129% | +$171K | 0.08% | 103 |
|
|
2022
Q3 | $236K | Sell |
816
-1,826
| -69% | -$528K | 0.08% | 99 |
|
|
2022
Q2 | $744K | Sell |
2,642
-2,254
| -46% | -$635K | 0.19% | 82 |
|
|
2022
Q1 | $1.28M | Buy |
4,896
+146
| +3% | +$38.1K | 0.33% | 69 |
|
|
2021
Q4 | $1.04M | Buy |
4,750
+551
| +13% | +$121K | 0.28% | 78 |
|
|
2021
Q3 | $762K | Buy |
4,199
+69
| +2% | +$12.5K | 0.22% | 81 |
|
|
2021
Q2 | $833K | Sell |
4,130
-587
| -12% | -$118K | 0.25% | 78 |
|
|
2021
Q1 | $1.01M | Buy |
+4,717
| New | +$1.01M | 0.3% | 77 |
|